New payment models may mean more of the people who need these treatments can get them.
FDA approval of aducanumab (Aduhelm) was contentious. Its submission to Health Canada for approval highlights concerns about evidence, independence and transparency in Canada’s drug approval process.
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
It’s not the price of health care that should concern us. It’s the cost. There’s a distinction, and it matters. Here’s why.
Support for over-the-counter birth control pills is growing. But a drawback could be that insurers would not pay for them. Also, some people have safety concerns. Could pharmacists be the solution?
CVS, which operates nearly 10,000 pharmacies across the country, announced intentions to buy Aetna, the nation’s third-largest provider of health insurance. Here’s how consumers could be affected.
Have you ever wondered why some drugs are so cheap, and others so expensive? Here’s why.